R&D Systems Recombinant Human PSG-1 Protein CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9334P1050
DescriptionThe Recombinant Human PSG1 Protein is derived from NS0. The Recombinant Human PSG1 Protein has been validated for the following applications: Bioactivity.
|>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|Mouse myeloma cell line, NS0-derived Gln35-Pro419, with a C-terminal 6-His tag|
|<0.10EU per 1μg of the protein by the LAL method.|
|Lyophilized from a 0.2μm filtered solution in PBS with trehalose.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 2 weeks, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|B1G1, B1G1CD66 antigen-like family member F, CD66f, CD66f antigen, DHFRP2, Fetal liver non-specific cross-reactive antigen 1/2, FLJ90598, FLJ90654, FL-NCA-1/2, PBG1, pregnancy specific beta-1-glycoprotein 1, pregnancy-specific B-1 glycoprotein, Pregnancy-specific beta-1 glycoprotein C/D, pregnancy-specific beta-1-glycoprotein 1, Pregnancy-specific glycoprotein 1, PS-beta-C/D, PS-beta-G-1, PSbG1, PSBG-1, PSBG1SP1, PSG1, PSG95, PSGGA, PSGGAPSG95, PSGIIA|
|Reconstitute at 500μg/mL in PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok